Chimerna Therapeutics

Business Services · New York, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

3960 Broadway, New York City, New York, ...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Chimerna Therapeutics

Chimerna Therapeutics specializes in developing innovative RNA therapeutics, focusing on overcoming RNA instability through their proprietary Tornado technology. Their platform generates highly stable circular RNA solutions aimed at treating a variety of diseases, including Alzheimer's, Parkinson's, ALS, and NASH. The company is committed to advancing the next generation of RNA-based therapeutics and has a team of experienced scientists leading the research and development efforts. Chimerna's intended clients include pharmaceutical companies and healthcare providers seeking cutting-edge therapeutic solutions.Explore more
Chimerna Therapeutics's Social MediaPopular SearchesChimerna TherapeuticsChimerna Therapeutics IncSIC Code 87,873NAICS Code 54,541Show more

Chimerna Therapeutics Org Chart

Brian Pickering, Chief Executive Officer & Co-Founder at Chimerna Therapeutics
United States flag for contact location.

Chief Executive Officer & Co-Founder

PhoneEmail
JL
United States flag for contact location.

Chief Scientific Officer and Co-Founder

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Chimerna Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Chimerna Therapeutics

Compare insights from companies similar to Chimerna Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Chimerna Therapeutics

<$5M
1-10
Private
-
-
Brian Pickering, Chief Executive Officer & Co-Founder at Chimerna Therapeutics
Brian PickeringCEO & Co-Founder
$10.5M
1-10
Private
-
2010
GX
Gaoping XiaoVice President, Business Development
$5.4M
11-50
Private
-
2013
GC
Guoqing ChenPresident & CEO
<$5M
11-50
Private
-
1996
KD
Krisha DoshiManager, Product Marketing
<$5M
11-50
Private
<$5M
1997
MW
Marisa WestlinDirector, Business Development
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
2010
KW
Karen WuPresident & Co-Founder
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Chimerna Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Chimerna Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Chimerna Therapeutics.

Chimerna Therapeutics Tech Stack

A closer look at the technologies used by Chimerna Therapeutics

Top Business Services Companies

Frequently Asked Questions Regarding Chimerna Therapeutics

What is Chimerna Therapeutics's official website?
Chimerna Therapeutics's official website is www.chimerna.com
What is Chimerna Therapeutics's Revenue?
Chimerna Therapeutics's revenue is <$5 Million
What is Chimerna Therapeutics's SIC code?
Chimerna Therapeutics's SIC: 87,873
What is Chimerna Therapeutics's NAICS code?
Chimerna Therapeutics's NAICS: 54,541
How many employees does Chimerna Therapeutics have?
Chimerna Therapeutics has 1-10 employees
What industry does Chimerna Therapeutics belong to?
Chimerna Therapeutics is in the industry of: Business Services, Research & Development
What is Chimerna Therapeutics competition?
Chimerna Therapeutics top competitors include: Cell Transfection, Lucerna, Syd Labs, SBH Sciences
What technology does Chimerna Therapeutics use?
Some of the popular technologies that Chimerna Therapeutics uses are: Sentry, F5 BIG-IP Platform, Sectigo, The USERTRUST Network
What does Chimerna Therapeutics do?

Chimerna Therapeutics specializes in developing innovative RNA therapeutics, focusing on overcoming RNA instability through their proprietary Tornado technology. Their platform generates highly stable circular RNA solutions aimed at treating a variety of diseases, including Alzheimer's, Parkinson's, ALS, and NASH. The company is committed to advanc... ing the next generation of RNA-based therapeutics and has a team of experienced scientists leading the research and development efforts. Chimerna's intended clients include pharmaceutical companies and healthcare providers seeking cutting-edge therapeutic solutions.Read More

What are Chimerna Therapeutics social media links?
Chimerna Therapeutics Linkedin page
Is Chimerna Therapeutics a public company?
Chimerna Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Chimerna Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.